Pyridazine derivatives XIV. Study of the vasorelaxant action of 6-aryl-5-piperidino-3-hydrazinopyridazines in isolated rat thoracic aorta: Comparison with hydralazine

Baker, 1985, Autoradiographic study of the distribution of [3H]-and [14C]-hydralazine in the rat, Br. J. Pharmac., 84, 107

Baker, 1992, Subcellular distribution of hydralazine in rat single vascular muscle cells, Cell Biol. Int. Rep., 16, 1023, 10.1016/S0309-1651(06)80055-X

Bardán, 1992, Caracterización de adrenoceptores alfa postsinápticos y estudio del mecanismo de la acción vasodilatadora de la hidralazina en la aorta de rata

Bardán, 1989, Estudios que cuestionan la modulación por el endotelio de los efectos vasodilatadores de la hidralazina en la aorta de rata, Rev. Farmacol. Clin. Exp., 6, 251

Bullock, 1985, No evidence for an endothelial component in the relaxant effect of hydralazine on rat aorta, Br. J. Pharmac., 85, 269P

Campos, 1996, La hidralazina: 50 años de investigación farmacológica 1, Rev. OFIL, 6, 115

Campos, 1996, La hidralazina: 50 años de investigación farmacológica II, Rev. OFIL, 6, 189

Campos-Toimil, 1994, Influence of CaCl2 concentration and of hydralazine on 45Ca2+ influx in isolated aorta of normotensive (WKY) and spontaneously hypertensive rats (SHR), Can. J. Pharmac., 72, 183

Campos-Toimil, 1994, Pharmacological study of several effects of hydralazine in the bisected rat vas deferens, Eur. J. Pharmac., 251, 83, 10.1016/0014-2999(94)90446-4

Clark, 1981, Methods for general tissue, 105

Clozel, 1990, Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats, Hypertension, 16, 532, 10.1161/01.HYP.16.5.532

Criscione, 1986, Hydralazine and its metabolites: in vitro and in vivo activity in the rat, J. Cardiovasc. Pharmac., 8, 420, 10.1097/00005344-198603000-00028

Diamond, 1978, Increases in cyclic GMP levels may not mediate relaxant effects of sodium nitroprusside, verapamil and hydralazine in rat vas deferens, Nature, 271, 472, 10.1038/271472a0

Eleno, 1987, Hydralazine-relaxing effect on rat aorta is not mediated through changes in ATPase activity, Arch. Int. Pharmacodyn. Ther., 285, 72

Fukuda, 1994, Hypoxia modifies the vasodilatory effects of nitroglycerin, prostaglandin E1 and hydralazine on isolated porcine coronary arteries, J. Cardiovasc. Pharmac., 23, 852, 10.1097/00005344-199405000-00024

Gil-Longo, 1993, Pyridazine derivatives XI: antihypertensive activity of 3-hydrazinocycloheptyl [1,2-c] pyridazine and its hydrazone derivatives, J. Pharm. Sci., 82, 286, 10.1002/jps.2600820314

Gil-Longo, 1992, Role of the endothelial system in BAY K 8644 enantiomer and nifedipine vasomodulator action in rat aorta, Eur. J. Pharmac., 221, 1, 10.1016/0014-2999(92)90765-V

Gurney, 1994, Mechanisms of drug-induced vasodilation, J. Pharm. Pharmac., 46, 242, 10.1111/j.2042-7158.1994.tb03789.x

Gurney, 1995, Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine, Br. J. Pharmac., 114, 238, 10.1111/j.1476-5381.1995.tb14931.x

Hasegawa, 1991, Effect of hydralazine on the blood flow in tumors and normal tissues in rats, Int. J. Radiat. Oncol. Biol. Phys., 20, 1001, 10.1016/0360-3016(91)90197-C

Hersmeyer, 1983, Effect of hydralazine on tension and membrane potential in the rat caudal artery, J. Pharmac. Exp. Ther., 227, 322

Horsman, 1995, Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours, Br. J. Cancer, 72, 1474, 10.1038/bjc.1995.532

Jacobs, 1984, Mechanism of action of hydralazine on vascular smooth muscle, Biochem. Pharmac., 33, 2915, 10.1016/0006-2952(84)90216-8

Karaki, 1988, Calcium release in smooth muscle, Life Sci., 42, 111, 10.1016/0024-3205(88)90674-1

Kauffman, 1986, Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine, J. Cardiovasc. Pharmac., 8, 1195, 10.1097/00005344-198611000-00015

Khayyal, 1981, Studies on the direct vasodilator effect of hydralazine in the isolated rabbit renal artery, J. Pharmac. Exp. Ther., 216, 390

Koch, 1990, An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta, Naunyn Schmiedeberg's Arch. Pharmac., 342, 454, 10.1007/BF00169464

Kruszyna, 1987, Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators, Toxicol. Appl. Pharmac., 91, 429, 10.1016/0041-008X(87)90064-0

Lipe, 1981, In vitro differences between human arteries and veins in their responses to hydralazine, J. Pharmac. Exp. Ther., 217, 204

Matsui, 1994, Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli, Arch. Int. Pharmacodyn. Ther., 283, 124

McLean, 1978, Study of in vitro effects of hydralazine metabolites, 235, 19

Moína, 1994, Effects of hydralazine on contractile responses to α1 and α2-adrenoceptor agonists in isolated rubbed rat aorta, Gen. Pharmac., 25, 165, 10.1016/0306-3623(94)90028-0

Muramatsu, 1990, Pharmacological subclassification of α1-adrenoceptors in vascular smooth muscle, Br. J. Pharmac., 99, 197, 10.1111/j.1476-5381.1990.tb14678.x

Nelson, 1990, Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone, Am. J. Physiol., 259, C3, 10.1152/ajpcell.1990.259.1.C3

Nishizuka, 1984, The role of protein kinase C in cell surface signal transduction and tumor promotion, Nature, 308, 693, 10.1038/308693a0

Noguera, 1992, Different and common intracellular calcium-stores mobilized by noradrenaline and caffeine in vascular smooth muscle, Naunyn Schmiedeberg's Arch. Pharmac., 345, 333, 10.1007/BF00168695

Noguera, 1993, Participation of intracellular calcium stores in serotonin-induced contractions in rat aorta, Pharmacology, 47, 145, 10.1159/000139091

Orallo, 1996, Regulation of cytosolic calcium levels in vascular smooth muscle, Pharmac. Ther., 69, 153, 10.1016/0163-7258(95)02042-X

Orallo, 1990, Diferente sensibilidad de la aorta de ratas normotensas y genéticamente hipertensas (SHR) a la acción de la hidralazina, 12, 211

Orallo, 1991, Comparison of the effects of hydralazine and nifedipine on contractions and 14Ca influx of rat aorta, J. Pharm. Pharmac., 43, 356, 10.1111/j.2042-7158.1991.tb06704.x

Polson, 1996, Cyclic nucleotide phosphodiesterases and vascular smooth muscle, Annu. Rev. Pharmac. Toxicol., 36, 403, 10.1146/annurev.pa.36.040196.002155

Quast, 1992, Potassium channel openers: pharmacological and clinical aspects, Fundam. Clin. Pharmac., 6, 279, 10.1111/j.1472-8206.1992.tb00122.x

Raviña, 1991, Pyridazine derivatives VIII: Synthesis and antihypertensive activity of 6-(2-thienyl)-5-aminomethyl-3-hydrazinopyridazines, Arch. Pharm. (Weinheim), 324, 455, 10.1002/ardp.19913240710

Shepherd, 1979, Hydralazine disposition following a single oral dose in human volunteers, Clin. Res., 27, 318

Sorrentino, 1993, Ryanodine receptors: how many, where and why?, Trends Pharmac. Sci., 14, 98, 10.1016/0165-6147(93)90072-R

Spokas, 1983, Endothelial mechanism in the vascular action of hydralazine, Hypertension, 5, I-107, 10.1161/01.HYP.5.2_Pt_2.I107

Sunahara, 1996, Complexity and diversity of mammalian adenylyl cyclases, Annu. Rev. Pharmac. Toxicol., 36, 461, 10.1146/annurev.pa.36.040196.002333

von der Weid, 1993, Effects of ATP on cultured smooth muscle cells from rat aorta, Br. J. Pharmac., 108, 638, 10.1111/j.1476-5381.1993.tb12854.x

Weiss, 1981, Contrast between actions of two calcium channel inhibitors and hydralazine on tension and on uptake and mobilization of 45Ca in rabbit aortic smooth muscle, Blood Vessels, 18, 230

Yen, 1989, Effects of hydralazine on guanosine cyclic 3',5'-monophosphate levels in rat aorta, 13, 83